Manufacturer
Mayne Pharma Inc.
9 drugs, 11 product strengths, 6 recalls on record.
Drugs Mayne Pharma Inc. makes
Doxycycline+1.7%Generic · 78 makersPharmacies pay from$3.13Being discontinued1 open recallMetronidazole+0.2%Generic · 56 makersPharmacies pay from$3.13UnavailableClobetasol+3.5%Generic · 38 makersPharmacies pay from$3.564 open recallsEthinyl estradiol / norethindrone-2.9%Generic · 18 makersPharmacies pay from$0.133 open recallsIvermectin+1.0%Generic · 32 makersPharmacies pay from$60.84Being discontinuedFluorouracil+5.2%Generic · 18 makersPharmacies pay from$25.89Adapalene / benzoyl peroxide+3.4%Generic · 12 makersPharmacies pay from$17.43Tazarotene-1.0%Generic · 7 makersPharmacies pay from$57.17Ethinyl estradiol / norgestrel-2.3%Generic · 5 makersPharmacies pay from$0.30
Recalls
Class IITerminatedJun 29, 2022Clonidine Transdermal SystemDefective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.Mayne Pharma Inc · D-1152-2022Class IIOngoingJan 26, 2022LexetteCGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.Mayne Pharma Inc · D-0387-2022Class IITerminatedMar 18, 2020Carbidopa and Levodopa TabletsProduct Mix-Up: A foreign tablet was found in bottle.Mayne Pharma Inc · D-0998-2020Class IIITerminatedSep 5, 2018Oxycodone and Acetaminophen TabletsLabeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct...Mayne Pharma Inc · D-1129-2018Class IIITerminatedApr 11, 2018Fabior (tazarotene) FoamSuperpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.Mayne Pharma Inc · D-0616-2018Class IITerminatedDec 6, 2017Liothyronine Sodium TabletsFailed Dissolution Specifications.Mayne Pharma Inc · D-0098-2018
About Mayne Pharma Inc.
No comments yet. Questions, tips, what worked for you - start the conversation.